GGrantIndex
Sort

50,496 grants matching lung cancer

Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung

$546,151
Shioko Kimura · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Targeting Lymph Node Dependent Immune Tolerance in Cancer

$546,149
Edgar G. Engleman · Stanford University · R01 · FY2025 · CA

Incorporating residential histories into assessment of cancer risk in a predominantly low-income and racially diverse population

$546,132
Melinda Aldrich · Vanderbilt University Medical Center · R01 · FY2024 · CA

Alternative MHCII Processing of Influenza Virus Proteins

$546,128
Laurence Crane Eisenlohr · Children'S Hosp Of Philadelphia · R01 · FY2017 · AI

Systemic RNA Delivery to Tumors

$546,127
Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2023 · CA

Systemic RNA Delivery to Tumors

$546,127
Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2025 · CA

Evaluating Lung Cancer Screening Patterns and Outcomes in Diverse Populations and Settings

$546,105
Louise Henderson · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA

The NYU Women's Health Study

$546,090
Yu Chen · New York University School Of Medicine · U01 · FY2021 · CA

Novel radioimmunoconjugates for targeted alpha-particle therapy of metastatic prostatic cancer

$546,037
Jiang He · University Of Virginia · R01 · FY2022 · CA

Novel functions of PlexinB2 in circulating tumor cell clusters

$545,983
Huiping Liu · Northwestern University At Chicago · R01 · FY2025 · CA

Towards Translation of MU-CN29: New Therapeutic Nanoparticle for Drug-Resistant NSCLC

$545,975
Raghuraman Kannan · University Of Missouri-Columbia · R01 · FY2024 · CA

Targeting polo-like kinase 1 (PLK1) for treatment of small cell lung cancer

$545,942
Taofeek K Owonikoko · University Of Maryland Baltimore · R01 · FY2023 · CA

Health Effects Of Exposures In Agriculture

$545,852
Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES

I-SCREEN: Increasing Screening for Cancer using a Randomized Evaluation of EHR-based Nudges

$545,847
Amol S Navathe · University Of Pennsylvania · R33 · FY2024 · AG

Taxi STEP (Social networks, Technology, and Exercise through Pedometers)

$545,716
Francesca M Gany · Sloan-Kettering Inst Can Research · U01 · FY2020 · MD

Target discovery and combination therapy in KRAS mutant cancer

$545,711
Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Organoid models of KRAS mutant cancer

$545,711
Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

RESTORATION OF IMMUNE SURVEILLANCE IN LUNG CANCER BY NATURAL KILLER CELLS

$545,693
H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. · · FY2015 · Department of the Army

Identifying and understanding drivers of chemoresistance in small cell lung cancer

$545,661
David Macpherson · Fred Hutchinson Cancer Center · R01 · FY2025 · CA

Identifying and understanding drivers of chemoresistance in small cell lung cancer

$545,661
David Macpherson · Fred Hutchinson Cancer Center · R01 · FY2023 · CA

Biodegradable, Biocompatible Pressure Sensitive Adhesives

$545,646
Mark W Grinstaff · Boston University (Charles River Campus) · R01 · FY2024 · HL

Bispecific T cell engager targeting a highly specific tumor cell surface antigen

$545,644
Bin Liu · University Of California, San Francisco · R01 · FY2025 · CA

Biophysical roles of pre-metastatic niche evolution on transport of circulating tumor cells

$545,607
Kenji Yokoi · Methodist Hospital Research Institute · U01 · FY2020 · CA

Fatty Acid Synthase Inhibitors: Ovarian Cancer Therapy

$545,559
Albert H. Owens · Fasgen, Inc. · R44 · FY2007 · CA

Effect of Neonatal Hyperoxia on Alveolar Development and Infection

$545,481
Michael A O'Reilly · University Of Rochester · R01 · FY2018 · HL